Why were Trump’s tariffs reinstated by appeals court?
How did Nvidia’s earnings impact chip stocks today?
What caused the US Court to block Trump’s tariffs?
Why is UnitedHealth Group’s CEO pay package controversial?
How are US-China trade talks affecting global markets?
Why is Victoria’s Secret website down due to security?
How is AI adoption affecting tech company hiring?
Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45%
benzinga.com/general/biotech/25/05/45676544/keros-therapeutics-stops-pah-drug-development-shrinks-workforce-by-45
Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in combination with background therapy in patients with pulmonary arterial hypertension (PAH) on Wednesday.
In December 2024, the company voluntarily halted the 3.0 mg/kg and…
This story appeared on benzinga.com, 2025-05-29 16:54:09.